You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 27, 2025

Drug Price Trends for NDC 70000-0044


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 70000-0044

Drug NameNDCPrice/Unit ($)UnitDate
STOMACH RLF 525 MG/30 ML SUSP 70000-0044-01 0.01518 ML 2025-04-23
STOMACH RLF 525 MG/30 ML SUSP 70000-0044-02 0.01177 ML 2025-04-23
STOMACH RLF 525 MG/30 ML SUSP 70000-0044-01 0.01531 ML 2025-03-19
STOMACH RLF 525 MG/30 ML SUSP 70000-0044-02 0.01144 ML 2025-03-19
STOMACH RLF 525 MG/30 ML SUSP 70000-0044-01 0.01554 ML 2025-02-19
STOMACH RLF 525 MG/30 ML SUSP 70000-0044-02 0.01119 ML 2025-02-19
STOMACH RLF 525 MG/30 ML SUSP 70000-0044-01 0.01581 ML 2025-01-22
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 7 of 7 entries

Best Wholesale Price for NDC 70000-0044

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 70000-0448

Introduction

The National Drug Code (NDC) 70000-0448 identifies a specific drug product, in this case, Leader Mineral Oil, a lubricant laxative. To conduct a comprehensive market analysis and make price projections for this drug, we need to consider several factors, including regulatory requirements, market trends, and pricing dynamics.

Regulatory Framework

The FDA's National Drug Code Directory is a crucial resource for understanding the regulatory environment surrounding drug products. The NDC Directory contains information on all finished and unfinished drugs, including those with NDCs like 70000-0448. This directory is updated daily and includes details such as the marketing start and end dates, and the labeler information[1].

Product Information

Leader Mineral Oil, identified by NDC 70000-0448, is an over-the-counter (OTC) monograph drug used for the relief of occasional constipation or irregularity. It is manufactured, packaged, and labeled by Pharma Nobis, LLC, and distributed by Cardinal Health[4].

Market Trends

The pharmaceutical market is influenced by various factors, including pricing trends, regulatory changes, and consumer demand.

Pricing Trends

In the U.S., prescription drug prices have seen significant increases over the years. For example, between 2018 and 2023, many drugs experienced list price increases ranging from 20% to 55%[2][5].

However, for OTC drugs like Leader Mineral Oil, pricing is generally more stable and less subject to the dramatic fluctuations seen in prescription drugs. The prices of OTC drugs are often determined by market forces and consumer demand rather than through complex negotiation processes.

International Pricing Comparison

The U.S. has some of the highest drug prices globally. On average, drug prices in the U.S. are 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world (excluding the U.S.)[3].

Price Projections

Given the stable nature of OTC drug pricing, here are some key points to consider for price projections:

Current Pricing

As of the latest available data, the pricing for Leader Mineral Oil is not subject to the same negotiation processes as prescription drugs. The price is set by the manufacturer and distributor based on market conditions.

Future Pricing Trends

  • Stability: OTC drugs tend to have more stable pricing compared to prescription drugs. Therefore, significant price increases or decreases are less likely.
  • Inflation: Prices may adjust slightly with inflation, but these changes are typically minor.
  • Market Demand: Changes in consumer demand or the introduction of new competitors could influence pricing, but such impacts are usually gradual.

Impact of Regulatory Changes

While the Medicare Drug Price Negotiation Program significantly affects prescription drug prices, it does not directly impact OTC drugs like Leader Mineral Oil. However, broader regulatory changes or shifts in healthcare policies could indirectly influence the market for all drug products.

Consumer and Market Dynamics

Consumer behavior and preferences play a crucial role in the demand for OTC drugs. Factors such as brand loyalty, product efficacy, and marketing efforts can influence sales and pricing.

Key Takeaways

  • Regulatory Compliance: Leader Mineral Oil complies with FDA regulations and is listed in the NDC Directory.
  • Pricing Stability: OTC drugs like Leader Mineral Oil generally have stable pricing.
  • Market Trends: The U.S. pharmaceutical market is characterized by high prices, but OTC drugs are less affected by dramatic price fluctuations.
  • Future Projections: Prices for Leader Mineral Oil are likely to remain stable with minor adjustments for inflation or changes in market demand.

FAQs

Q: What is the National Drug Code (NDC) and how is it used? A: The NDC is a unique three-segment number used by the FDA to identify drug products. It is essential for tracking and regulating drugs in the U.S.[1].

Q: How do price negotiations affect OTC drugs? A: Price negotiations, such as those under the Medicare Drug Price Negotiation Program, do not directly affect OTC drugs. These negotiations primarily impact prescription drugs[2][5].

Q: What factors influence the pricing of OTC drugs? A: Pricing of OTC drugs is influenced by market forces, consumer demand, and minor adjustments for inflation. Regulatory changes and broader market trends also play a role[3].

Q: How does the U.S. compare to other countries in terms of drug prices? A: The U.S. has significantly higher drug prices compared to other countries, with prices being 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world (excluding the U.S.)[3].

Q: What is the expected impact of inflation on OTC drug prices? A: Inflation may cause minor price adjustments, but these changes are typically gradual and do not significantly impact the overall pricing stability of OTC drugs.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Medicare Drug Price Negotiation Program - ASPE, HHS.gov
  3. International Market Size and Prices - ASPE
  4. Label: LEADER MINERAL OIL - DailyMed
  5. Medicare Drug Price Negotiation Program - CMS

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.